Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes
Abstract
Authors
P.D. Home P. Soewondo Z. Hussein A.A. Shafie K. AlRaddady R. Baadbad E. Hammerby A. Nikolajsen M.F.B. Andersen O. Henriksen